Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(3)
DRUG(1)
Cyclophosphamide IV
1 trial
phase_2
assistance-publique-hôpitaux-de-paris
Immunoglobulin
1 trial
phase_2
assistance-publique-hôpitaux-de-paris
Methylprednisolone IV
1 trial
phase_2
assistance-publique-hôpitaux-de-paris
Immunoglobulins IV (CLAYRIG)
1 trial
phase_2
assistance-publique-hôpitaux-de-paris
4 unique interventions2 categories

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06373211Phase 2Recruiting
Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy
Paraneoplastic Sensory Neuronopathy
PrincipalinvestigatorStart date: 2025-01-10
NCT02343211Phase 2Completed
Immunotherapy and Paraneoplastic Neurological Syndromes
Paraneoplastic Neurological Syndromes
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Paraneoplastic Neurological Syndromes1Paraneoplastic Sensory Neuronopathy1paraneoplastic sensory neuropathy with anti-Hu antibodies1

Affiliations

Assistance Publique - Hôpitaux de Paris

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

Similar investigators will appear here based on research areas and collaboration patterns.

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06373211Phase 2PrincipalInvestigator

Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy

Paraneoplastic Sensory Neuronopathy
Recruiting
NCT02343211Phase 2PrincipalInvestigator

Immunotherapy and Paraneoplastic Neurological Syndromes

Paraneoplastic Neurological Syndromes
Completed

All 2 trials loaded